Efficacy of nepafenac ophthalmic suspension 0.1% in improving clinical outcomes following cataract surgery in patients with diabetes: an analysis of two randomized studies

OBJECTIVE: To assess the efficacy of nepafenac 0.1% ophthalmic suspension in improving the clinical outcomes following cataract surgery (CS) in patients with nonproliferative diabetic retinopathy. METHODS: In two similar multicenter, randomized studies, patients received either nepafenac 0.1% or veh...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Rishi P, Staurenghi, Giovanni, Pollack, Ayala, Adewale, Adeniyi, Walker, Thomas M, Sager, Dana, Lehmann, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457150/
https://www.ncbi.nlm.nih.gov/pubmed/28603408
http://dx.doi.org/10.2147/OPTH.S132030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457150/
https://www.ncbi.nlm.nih.gov/pubmed/28603408
http://dx.doi.org/10.2147/OPTH.S132030

Ejemplares similares